Drug donanemab seen as turning point in dementia fight (www.bbc.com) The antibody treatment donanemab slows clinical decline by around a third, a large trial confirms.
Drug donanemab seen as turning point in dementia fight (www.bbc.com)
The antibody treatment donanemab slows clinical decline by around a third, a large trial confirms.